Potential role of genipin in cancer therapy

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Muthu K ShanmugamGautam Sethi

Abstract

Genipin, an aglycone derived from the iridoid glycoside, geniposide, is isolated and characterized from the extract of Gardenia jasminoides Ellis fruit (family Rubiaceae). It has long been used in traditional oriental medicine for the prevention and treatment of several inflammation driven diseases, including cancer. Genipin has been shown to have hepatoprotective activity acting as a potent antioxidant and inhibitor of mitochondrial uncoupling protein 2 (UCP2), and also reported to exert significant anticancer effects. It is an excellent crosslinking agent that helps to make novel sustained or delayed release nanoparticle formulations. In this review, we present the latest developments of genipin as an anticancer agent and briefly describe its diverse mechanism(s) of action. Several lines of evidence suggest that genipin is a potent inhibitor of UCP2, which functions as a tumor promoter in a variety of cancers, attenuates generation of reactive oxygen species and the expression of matrix metalloproteinase 2, as well as induces caspase-dependent apoptosis in vitro and in in vivo models. These finding suggests that genipin can serve as both a prominent anticancer agent as well as a potent crosslinking drug that may find useful a...Continue Reading

Citations

Jun 27, 2020·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyun Jong KimJoo Hyun Nam
Jul 28, 2018·Frontiers in Immunology·Anusha AngajalaMing Tan
Dec 21, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Amrita Devi KhwairakpamAjaikumar B Kunnumakkara
Sep 10, 2020·MedChemComm·Geetha B KumarDavid B C Martin
Jan 11, 2020·Frontiers in Oncology·Douglas LemosFranklin David Rumjanek
Dec 12, 2020·Nutrition and Cancer·Connor ChestnutShrikant Anant
Jan 14, 2021·Scientific Reports·Patrícia Muniz de MedeirosRafael Ricardo Vasconcelos da Silva
Dec 10, 2020·Journal of Tissue Engineering·Zhonghan WangXiaoyu Yang
Jan 27, 2020·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Fayyaz AhmedTayyab Husnain
Jan 16, 2021·Journal of Orthopaedic Surgery and Research·Jiajia ZhangXin Xu
Dec 15, 2020·Reproductive Biology and Endocrinology : RB&E·Yihua XuZhigang Hu
Dec 15, 2020·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Zhong-Shang XiaJia-Gang Deng
Mar 7, 2021·Pharmaceuticals·Paula Garcia-OliveiraMiguel Angel Prieto
Nov 26, 2020·Food Research International·Livia DicksonFabrice Vaillant
Jun 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Milad AshrafizadehSaeed Samarghandian
Aug 12, 2021·Molecular Biology Reports·Nabil M Abdel-Hamid, Shimaa A Abass
Dec 29, 2019·Food Research International·Iramaia Angelica Neri-NumaGlaucia Maria Pastore
Jun 23, 2020·International Journal of Biological Macromolecules·Thaysa Ksiaskiewcz KaramCelso Vataru Nakamura
Dec 17, 2021·Journal of Mass Spectrometry : JMS·Lili SongHong Guo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.